For: | Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ, Hou BH. Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management. World J Gastroenterol 2020; 26(19): 2305-2322 [PMID: 32476795 DOI: 10.3748/wjg.v26.i19.2305] |
---|---|
URL: | https://www.wjgnet.com/1948-5190/full/v26/i19/2305.htm |
Number | Citing Articles |
1 |
Debamitra Chakraborty, Bradley N. Mills, Jing Cheng, Ivan Komissarov, Scott Gerber, Roman Sobolewski, Zeev Zalevsky, Valery V. Tuchin, Walter C. Blondel. Terahertz time-domain spectroscopy imaging of pancreatic ductal adenocarcinoma tissues. Tissue Optics and Photonics III 2024; : 4 doi: 10.1117/12.3023034
|
2 |
Vetri Sudar Jayaprakasam, Lisa Bodei. Neuroendocrine Tumor Therapy Response Assessment. PET Clinics 2023; 18(2): 267 doi: 10.1016/j.cpet.2022.11.009
|
3 |
Costanza Chiapponi, Christiane J Bruns. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. best practice onkologie 2022; 17(12): 598 doi: 10.1007/s11654-022-00451-y
|
4 |
Kieran J. Ved, Arjun Bhatt, Aidan M. Burke, Michael C. Larkins, Dishita Pandya, Constantin B. Marcu. Radioligand therapy (RLT) used to treat cardiac metastasis of pancreatic neuroendocrine tumor. Clinical Case Reports 2024; 12(3) doi: 10.1002/ccr3.8622
|
5 |
Yang Xie, Yudi Wang, Wenjie Pei, Yue Chen. Theranostic in GLP-1R molecular imaging: challenges and emerging opportunities. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1210347
|
6 |
Ryuta Muraki, Yoshifumi Morita, Kyota Tatsuta, Shinya Ida, Ryo Kitajima, Amane Hirotsu, Makoto Takeda, Hirotoshi Kikuchi, Yoshihiro Hiramatsu, Atsuko Fukazawa, Go Kuroda, Keisuke Kakizawa, Hiroya Takeuchi. Refractory postoperative Staphylococcus hominis bacteremia in a patient with an ACTH-producing pancreatic neuroendocrine neoplasm: a case report. Surgical Case Reports 2022; 8(1) doi: 10.1186/s40792-022-01485-8
|
7 |
Wentong Mei, Feng Cao, Jiongdi Lu, Chang Qu, Zhen Fang, Jia Li, Fei Li. Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1140873
|
8 |
Saneya A. Pandrowala, Deeksha Kapoor, Aditya Kunte, Amit Chopde, Ameya Puranik, Indraja Devidas Dev, Rahul Parghane, Sandip Basu, Anant Ramaswamy, Vikas Ostwal, Vikram A. Chaudhari, Manish S. Bhandare, Shailesh V. Shrikhande. Factors Predicting Prognosis in Metastatic Grade 1 Gastro-entero-pancreatic Neuroendocrine Tumors. Journal of Gastrointestinal Cancer 2024; 55(3): 1220 doi: 10.1007/s12029-024-01077-9
|
9 |
Xianzheng Qin, Taojing Ran, Yifei Chen, Yao Zhang, Dong Wang, Chunhua Zhou, Duowu Zou. Artificial Intelligence in Endoscopic Ultrasonography-Guided Fine-Needle Aspiration/Biopsy (EUS-FNA/B) for Solid Pancreatic Lesions: Opportunities and Challenges. Diagnostics 2023; 13(19): 3054 doi: 10.3390/diagnostics13193054
|
10 |
Giuseppe Curigliano, Miguel Martin, Komal Jhaveri, J.T. Beck, Giampaolo Tortora, Nicola Fazio, Michela Maur, Richard A. Hubner, Harald Lahner, Valerie Donnet, Olga Ajipa, Zheng Li, Lars Blumenstein, Fabrice Andre. Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study. European Journal of Cancer 2021; 151: 49 doi: 10.1016/j.ejca.2021.03.042
|
11 |
Ajitha Ramesh, Aniruddha Chatterjee, Rathan M. Subramaniam. Neuroendocrine Neoplasms. PET Clinics 2023; 18(2): 161 doi: 10.1016/j.cpet.2022.10.002
|
12 |
Agnieszka Milewska-Kranc, Jarosław B. Ćwikła, Agnieszka Kolasinska-Ćwikła. The Role of Receptor–Ligand Interaction in Somatostatin Signaling Pathways: Implications for Neuroendocrine Tumors. Cancers 2023; 16(1): 116 doi: 10.3390/cancers16010116
|
13 |
Miłosz Caban, Ewa Małecka-Wojciesko. Pancreatic Incidentaloma. Journal of Clinical Medicine 2022; 11(16): 4648 doi: 10.3390/jcm11164648
|
14 |
Georgina E. Riddiough, Sze C. Tan, Stephen Farrell. Laparoscopic insulinoma enucleation for an uncinate lesion. ANZ Journal of Surgery 2024; 94(7-8): 1404 doi: 10.1111/ans.19106
|
15 |
Alexander M. Prete, Tamas A. Gonda. Endoscopic Ultrasound-Guided Local Ablative Therapies for the Treatment of Pancreatic Neuroendocrine Tumors and Cystic Lesions: A Review of the Current Literature. Journal of Clinical Medicine 2023; 12(9): 3325 doi: 10.3390/jcm12093325
|
16 |
Hai-Yan Chen, Yao Pan, Jie-Yu Chen, Lu-lu Liu, Yong-Bo Yang, Kai Li, Ri-Sheng Yu, Guo-Liang Shao. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas. European Radiology 2022; 32(12): 8317 doi: 10.1007/s00330-022-08891-4
|
17 |
Renato Patrone, Federico Maria Mongardini, Alessandra Conzo, Chiara Cacciatore, Giovanni Cozzolino, Antonio Catauro, Eduardo Lanza, Francesco Izzo, Andrea Belli, Raffaele Palaia, Luigi Flagiello, Ferdinando De Vita, Ludovico Docimo, Giovanni Conzo. Pancreatic Neuroendocrine Tumors: What Is the Best Surgical Option?. Journal of Clinical Medicine 2024; 13(10): 3015 doi: 10.3390/jcm13103015
|
18 |
Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review. Journal of Clinical Medicine 2023; 12(20): 6617 doi: 10.3390/jcm12206617
|
19 |
Qi Zhang, Yi-Jie Qiu, Dao-Hui Yang, Xiu-Yun Lu, Sheng Chen, Yi Dong, Wen-Ping Wang. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features. Clinical Hemorheology and Microcirculation 2023; 85(4): 421 doi: 10.3233/CH-231932
|
20 |
G. Vivanet, L. Gervaso, A. Laffi, M. Rubino, F. Spada, N. Fazio. Ten years-experience of sunitinib in the treatment of advanced pan-NETs: an update on safety profile. Expert Opinion on Drug Safety 2022; 21(3): 303 doi: 10.1080/14740338.2022.2000964
|
21 |
Andrew C. Baek, Kenny Wise, Emanuela C. Peshel. Anesthesia for Oncological Surgery. 2023; : 349 doi: 10.1007/978-3-031-50977-3_53
|
22 |
Anna Battistella, Matteo Tacelli, Paola Mapelli, Marco Schiavo Lena, Valentina Andreasi, Luana Genova, Francesca Muffatti, Francesco De Cobelli, Stefano Partelli, Massimo Falconi. Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms. Expert Review of Gastroenterology & Hepatology 2024; 18(4-5): 155 doi: 10.1080/17474124.2024.2342837
|
23 |
Megan Casey, Audrey Brown, Fernanda Romero-Hernandez, Jaeyun Jane Wang, Amir Ashraf Ganjouei, Francesca Tozzi, Nikdokht Rashidian, Kimberly Kirkwood, Carlos Corvera, Eric Nakakura, Adnan Alseidi, Mohamed Adam. National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis. The American Journal of Surgery 2024; 235: 115779 doi: 10.1016/j.amjsurg.2024.115779
|
24 |
Mahmoud Sultan, Azad Al Hasan, Nisreen Khazem. Liver metastasized pancreatic neuroendocrine tumor in a 17‐year‐old female: A case report. Clinical Case Reports 2024; 12(11) doi: 10.1002/ccr3.9545
|
25 |
Cheng Wei, Yi-Chen Li, Hong-Tao Jin, De-Feng Li, Li-Sheng Wang, Jun Yao. Early detection of pancreatic cancer in patients with recurrent pancreatitis: A case report. World Journal of Clinical Cases 2024; 12(19): 3936-3941 doi: 10.12998/wjcc.v12.i19.3936
|
26 |
Yanhao Ren, Duowu Zou, Wanqian Xu, Xuesong Zhao, Wenlian Lu, Xiangyi He. Bimodal segmentation and classification of endoscopic ultrasonography images for solid pancreatic tumor. Biomedical Signal Processing and Control 2023; 83: 104591 doi: 10.1016/j.bspc.2023.104591
|
27 |
Yan Zhang, Yanchun Wang, Jingjing Wu, Zhihong Zhong, Jie Li, Xi Chen. Sustained response to anlotinib in advanced pancreatic neuroendocrine carcinoma: A case report. Oncology Letters 2024; 27(4) doi: 10.3892/ol.2024.14271
|
28 |
Piero Alberti, David Martin, Georgios Gemenetzis, Rowan Parks. Surgical management of pancreatic neuroendocrine neoplasms. Laparoscopic, Endoscopic and Robotic Surgery 2023; 6(3): 83 doi: 10.1016/j.lers.2023.06.001
|
29 |
Yasir Alshareefy, Sinead Cummins, Adele Mazzoleni, Vidushi Sharma, Saibaba Guggilapu, Amanda Weng Yee Leong, Andrew Awuah Wireko. A review of functional pancreatic neuroendocrine tumors: Exploring the molecular pathogenesis, diagnosis and treatment. Medicine 2023; 102(46): e36094 doi: 10.1097/MD.0000000000036094
|
30 |
Sunil Kumar, E. M. Thrijil Krishnan, Neethu Kesavan, K. Thiyagaraj, Kumari Neelam. Role of Ayurveda in symptomatic management of pancreatic neuro endocrine tumor - An experience. Journal of Ayurveda Case Reports 2022; 5(3): 112 doi: 10.4103/jacr.jacr_114_21
|
31 |
Guanhua Chen, Li Liu, Chunlu Tan, Qingquan Tan, Yonghua Chen, Xiangrong An, Xubao Liu, Xing Wang. Prognostic significance of systemic immune‐inflammation index in patients with nonfunction pancreatic neuroendocrine tumor undergoing surgical resection. Cancer Medicine 2024; 13(7) doi: 10.1002/cam4.7114
|
32 |
Hao Zhou, Yong Zhu, Bin Qin, Yongkang Liu, Zhongqiu Wang, Chuangen Guo, Jianhua Wang, Xiao Chen. The association between non-HDL cholesterol and high-grade pancreatic neuroendocrine neoplasms. Endocrine 2024; 86(2): 584 doi: 10.1007/s12020-024-03910-4
|
33 |
Catherine H. Davis, Amanda M. Laird, Steven K. Libutti. Resistant gastroenteropancreatic neuroendocrine tumors: a definition and guideline to medical and surgical management. Baylor University Medical Center Proceedings 2024; 37(1): 104 doi: 10.1080/08998280.2023.2284039
|
34 |
Tulan Hu, Wei Wang, Chiyi He, Cristina Magi-Galluzzi. Second Primary Malignancies in Patients with Pancreatic Neuroendocrine Neoplasms: A Population-Based Study on Occurrence, Risk Factors, and Prognosis. Journal of Oncology 2021; 2021: 1 doi: 10.1155/2021/1565089
|
35 |
Aman Chauhan, Alexandre Prieur, Jill Kolesar, Susanne Arnold, Léa Payen, Younes Mahi, Berengere Vire, Madison Sands, B. Mark Evers, Dominique Joubert, Lowell Anthony. hPG80 (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors. Cancers 2022; 14(4): 863 doi: 10.3390/cancers14040863
|
36 |
Michele Bevere, Anastasios Gkountakos, Filippo Maria Martelli, Aldo Scarpa, Claudio Luchini, Michele Simbolo. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms. Biomedicines 2023; 11(2): 303 doi: 10.3390/biomedicines11020303
|
37 |
Radhika Chavan, Nirav Thosani, Shivangi Kothari. Role of Endoscopic Ultrasound-Guided Radiofrequency Ablation in Pancreatic Lesions: Where Are We Now and What Does the Future Hold?. Cancers 2024; 16(21): 3662 doi: 10.3390/cancers16213662
|
38 |
Tara Keihanian, Mohamed Othman. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_36-1
|
39 |
Bor-Shiuan Shyr, Bor-Uei Shyr, Shih-Chin Chen, Yi-Ming Shyr, Shin-E Wang. Impact of tumor grade on pancreatic neuroendocrine tumors. Asian Journal of Surgery 2022; 45(12): 2659 doi: 10.1016/j.asjsur.2022.01.094
|
40 |
Mohamed Zardab, Vickna Balarajah, Abhirup Banerjee, Konstantinos Stasinos, Amina Saad, Ahmet Imrali, Christine Hughes, Rhiannon Roberts, Ajith Vajrala, Claude Chelala, Hemant M. Kocher, Abu Z. M. Dayem Ullah. Differentiating Ductal Adenocarcinoma of the Pancreas from Benign Conditions Using Routine Health Records: A Prospective Case-Control Study. Cancers 2022; 15(1): 280 doi: 10.3390/cancers15010280
|
41 |
Chetan Parmar, Kamal Abi Mosleh, Pauline Aeschbacher, Thorvardur R. Halfdanarson, Travis J. McKenzie, Raul J. Rosenthal, Omar M. Ghanem, Helen M. Heneghan, Donal J. Brennan, Michael Wilkinson, Odhran Ryan, Francesk Mulita, Georgios Ioannis Verras, Emanuele Lo Menzo, Grigorios Christodoulidis, Farah Hussain, Franceso Greco, Rob Snoekx, Pierre B.G.M. Feskens, Tamer N. Abdelbaki, Javier Barrionuevo, Asim Shabbir, Simon P.L. Dexter. The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy. Surgery for Obesity and Related Diseases 2024; 20(8): 717 doi: 10.1016/j.soard.2024.02.008
|
42 |
Olesja Rogoza, Kaspars Megnis, Marija Kudrjavceva, Aija Gerina-Berzina, Vita Rovite. Role of Somatostatin Signalling in Neuroendocrine Tumours. International Journal of Molecular Sciences 2022; 23(3): 1447 doi: 10.3390/ijms23031447
|
43 |
Elena Codruța Gheorghe, Adrian Săftoiu. Pocket Guide to Advanced Endoscopy in Gastroenterology. 2023; : 423 doi: 10.1007/978-3-031-42076-4_42
|
44 |
Andrew J. H. Sedlack, Kimia Saleh-Anaraki, Suresh Kumar, Po Hien Ear, Kate E. Lines, Nitin Roper, Karel Pacak, Emily Bergsland, Dawn E. Quelle, James R. Howe, Yves Pommier, Jaydira del Rivero. Preclinical Models of Neuroendocrine Neoplasia. Cancers 2022; 14(22): 5646 doi: 10.3390/cancers14225646
|
45 |
Song-Chen Dong, Qi-Yun Tang, Lu Wang, Fang Fang, Dou-Sheng Bai, Sheng-Jie Jin, Bao-Huan Zhou, Guo-Qing Jiang. Characteristics and risk differences of different tumor sizes on distant metastases of pancreatic neuroendocrine tumors: A retrospective study in the SEER database. Hepatobiliary & Pancreatic Diseases International 2024; doi: 10.1016/j.hbpd.2024.07.001
|
46 |
J. Qi, H. Liu, Z. Zhou, Y. Jiang, W. Fan, J. Hu, J. Li, Z. Guo, M. Xie, W. Huang, Q. Zhang, S. Hou. Genome-wide association study identifies multiple loci influencing duck serum biochemical indicators in the laying period. British Poultry Science 2024; 65(1): 8 doi: 10.1080/00071668.2023.2272982
|
47 |
Priya Kumari Gorai, Simran Rastogi, Prahalad Singh Bharti, Shipra Agarwal, Sujoy Pal, Mehar Chand Sharma, Rakesh Kumar, Fredrik Nikolajeff, Saroj Kumar, Neerja Rani. Deciphering pancreatic neuroendocrine tumors: Unveiling through circulating small extracellular vesicles. Heliyon 2024; 10(7): e29079 doi: 10.1016/j.heliyon.2024.e29079
|
48 |
Wu-Hu Zhang, He-Li Gao, Wen-Sheng Liu, Yi Qin, Zeng Ye, Xin Lou, Fei Wang, Yue Zhang, Xue-Min Chen, Jie Chen, Xian-Jun Yu, Qi-Feng Zhuo, Xiao-Wu Xu, Shun-Rong Ji. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.941210
|
49 |
Adam Mylonakis, Michail Vailas, Panagiotis Sakarellos, Lysandros Karydakis, Eleandros Kyros, Spyridon Davakis, Alexandros Papalampros, Evaggelos Felekouras. A Case of a Metastatic Pancreatic Neuroendocrine Tumor: A Surgical Conundrum Wrapped in Functionality's Embrace. Cureus 2024; doi: 10.7759/cureus.56893
|
50 |
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseases. Journal of Pancreatology 2024; 7(3): 222 doi: 10.1097/JP9.0000000000000158
|
51 |
Yuxiang Liu, Nianshuang Li, Yin Zhu. Pancreatic Organoids: A Frontier Method for Investigating Pancreatic-Related Diseases. International Journal of Molecular Sciences 2023; 24(4): 4027 doi: 10.3390/ijms24044027
|
52 |
Osama O. Elkelany, Fred G. Karaisz, Benjamin Davies, Somashekar G. Krishna. An Overview of Pancreatic Neuroendocrine Tumors and an Update on Endoscopic Techniques for Their Management. Current Oncology 2023; 30(8): 7566 doi: 10.3390/curroncol30080549
|
53 |
Santosh Dev, Kailash Mani Pokhrel, Pashupati Pokharel, Ramesh Singh Bhandari, Sumita Pradhan. Castleman disease of the pancreas mimicking pancreatic neuroendocrine tumor: A rare case report. International Journal of Surgery Case Reports 2023; 109: 108524 doi: 10.1016/j.ijscr.2023.108524
|
54 |
Di Meng, Lei Zhao, Jinyang Liu, Chunlin Ge, Cheng Zhang. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors. Neuroendocrinology 2023; 113(7): 719 doi: 10.1159/000529966
|
55 |
N. V. Lyubimova, Yu. S. Timofeev, A. V. Lebedeva, N. E. Kushlinskii. Сравнительное исследование хромогранина А и хромогранина В у больных с нейроэндокринными опухолями желудка и поджелудочной железы. Advances in Molecular Oncology 2021; 8(3): 8 doi: 10.17650/2313-805X-2021-8-3-8-13
|
56 |
Tania Amin, Fabrice Viol, Jenny Krause, Martina Fahl, Corinna Eggers, Fayez Awwad, Benjamin Schmidt, Daniel Benten, Hendrik Ungefroren, Christoph Fraune, Till S. Clauditz, Guido Sauter, Jakob R. Izbicki, Ansgar W. Lohse, Samuel Huber, Jörg Schrader. Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine Tumors through STAT3 Activation. Neuroendocrinology 2023; 113(5): 501 doi: 10.1159/000528539
|
57 |
Tara Keihanian, Mohamed Othman. Hepato-Pancreato-Biliary Malignancies. 2022; : 623 doi: 10.1007/978-3-030-41683-6_36
|
58 |
Shruti Gupta, Atul Kumar, Kiran Kumar Tejavath. A pharmacognostic approach for mitigating pancreatic cancer: emphasis on herbal extracts and phytoconstituents. Future Journal of Pharmaceutical Sciences 2021; 7(1) doi: 10.1186/s43094-021-00246-y
|
59 |
Lucas P. Carlstrom, Jamie J. Van Gompel, Garret Choby. Olfactory Neuroblastoma: Treatment Strategies for Advanced Disease. Current Otorhinolaryngology Reports 2023; 11(2): 117 doi: 10.1007/s40136-023-00447-4
|
60 |
Xiangjun Li, Jiandong Zhang, Siqi Zhang, Shengling Shi, Yi’an Lu, Ying Leng, Chunyan Li. Biomarkers for neuromyelitis optica: a visual analysis of emerging research trends. Neural Regeneration Research 2024; 19(12): 2735 doi: 10.4103/NRR.NRR-D-24-00109
|
61 |
Lívia Sira, Noémi Zsíros, László Bidiga, Sándor Barna, Zsolt Kanyári, Edit B. Nagy, Nicolas Guillaume, Damian Wild, Katalin Rázsó, Szilvia Andó, István Balogh, Endre V. Nagy, Zoltán Balogh. Case report: Metastatic pancreatic neuroendocrine tumour associated with portal vein thrombosis; successful management with subsequent pregnancies. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1095815
|
62 |
Luigi Asmundo, Valentina Ambrosini, Mark A. Anderson, Stefano Fanti, William R. Bradley, Davide Campana, Amirkasra Mojtahed, Ryan Chung, Shaunagh Mcdermott, Subba Digumarthy, Stephan Ursprung, Konstantin Nikolau, Florian J. Fintelmann, Michael Blake, Carlos Fernandez-del Castillo, Motaz Qadan, Ankur Pandey, Jeffrey W. Clark, Onofrio A. Catalano. Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach. Journal of Computer Assisted Tomography 2024; 48(4): 614 doi: 10.1097/RCT.0000000000001596
|
63 |
Jiake Xu, Jie Yang, Ye Feng, Jie Zhang, Yuqiao Zhang, Sha Chang, Jingqiang Jin, Xia Du. MRI Feature-Based Nomogram Model for Discrimination Between Non-Hypervascular Pancreatic Neuroendocrine Tumors and Pancreatic Ductal Adenocarcinomas. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.856306
|
64 |
Hebin Wang, Ding Ding, Tingting Qin, Hang Zhang, Jun Liu, Junfang Zhao, Chien-Hui Wu, Ammar Javed, Christopher Wolfgang, Shiwei Guo, Qingmin Chen, Weihong Zhao, Wei Shi, Feng Zhu, Xingjun Guo, Xu Li, Feng Peng, Ruizhi He, Simiao Xu, Jikuan Jin, Yi Wu, Abula Nuer, Barish Edil, Yu-Wen Tien, Gang Jin, Lei Zheng, Jin He, Jianhua Liu, Yahui Liu, Min Wang, Renyi Qin. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors. HPB 2022; 24(5): 681 doi: 10.1016/j.hpb.2021.10.017
|
65 |
Qing-Wei Cheng, Hong-Li Shen, Zhi-Hui Dong, Qian-Qian Zhang, Ya-Fen Wang, Jin Yan, Yu-Sheng Wang, Ning-Gang Zhang. <i>Pneumocystis jirovecii</i> diagnosed by next-generation sequencing of bronchoscopic alveolar lavage fluid: A case report and review of literature. World Journal of Clinical Cases 2023; 11(4): 866-873 doi: 10.12998/wjcc.v11.i4.866
|
66 |
Haidi Chen, Zheng Li, Yuheng Hu, Xiaowu Xu, Zeng Ye, Xin Lou, Wuhu Zhang, Heli Gao, Yi Qin, Yue Zhang, Xuemin Chen, Jie Chen, Wei Tang, Xianjun Yu, Shunrong Ji. Maximum Value on Arterial Phase Computed Tomography Predicts Prognosis and Treatment Efficacy of Sunitinib for Pancreatic Neuroendocrine Tumours. Annals of Surgical Oncology 2023; 30(5): 2988 doi: 10.1245/s10434-022-12693-9
|
67 |
Andrei Havasi, Daniel Sur, Simona Sorana Cainap, Cristian-Virgil Lungulescu, Laura-Ioana Gavrilas, Calin Cainap, Catalin Vlad, Ovidiu Balacescu. Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers. International Journal of Molecular Sciences 2022; 23(3): 1109 doi: 10.3390/ijms23031109
|
68 |
Zhen Yang, Jie Liang, Kaiming Leng, Guangjun Shi. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.903560
|
69 |
Samuel Frey, Eric Mirallié, Maëlle Le Bras, Nicolas Regenet. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers 2021; 13(23): 5954 doi: 10.3390/cancers13235954
|
70 |
Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu, Xiao Chen. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01669-z
|
71 |
Hehe Tang, He Zhang, Dapeng Liu, Zhen Wang, Daxin Yu, Wenlei Fan, Zhanbao Guo, Wei Huang, Shuisheng Hou, Zhengkui Zhou. Genome-wide association study reveals the genetic determinism of serum biochemical indicators in ducks. BMC Genomics 2022; 23(1) doi: 10.1186/s12864-022-09080-9
|
72 |
Giraldo Cardona Joaquín, Licopanti Cinthia, Monteiro Agustina, Gonzalez Yasmin, Villegas Angelo Cesar, Otero Yamila, Buono Monica. Hypoglycemia in a non - diabetic patient: a case report. Journal of Diabetes, Metabolic Disorders & Control 2024; 11(2): 56 doi: 10.15406/jdmdc.2024.11.00278
|
73 |
Zhen Yang, Guangjun Shi. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database. European Journal of Surgical Oncology 2022; 48(10): 2181 doi: 10.1016/j.ejso.2022.05.016
|
74 |
X. Liu, B. Chen, J. Chen, Z. Su, S. Sun. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Journal of Endocrinological Investigation 2022; 46(7): 1373 doi: 10.1007/s40618-022-01985-2
|
75 |
Rafał Stankiewicz, Michał Grąt. Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastrointestinal Surgery 2022; 14(4): 276-285 doi: 10.4240/wjgs.v14.i4.276
|
76 |
Raafat Raoof Alturfi, Sabah Noori Abdulraheem, Noufel sh. Alshadood, Haider A. H. Ahmed, Aqeel Shakir Mahmood. MCQs in General Surgical Oncology. 2024; : 179 doi: 10.1007/978-3-031-65738-2_13
|
77 |
Darryl Mason, Robert Leimbach, Robert Kitz, Robert Vietor, Nicole Vietor. Calcitonin‐secreting pancreatic neuroendocrine tumor in a patient with elevated thyroid fine‐needle aspirate calcitonin washout: A case report and review of the literature. Clinical Case Reports 2022; 10(1) doi: 10.1002/ccr3.5296
|
78 |
Priya Kumari Gorai, Prahalad Singh Bharti, Shashi Kumar, Girish H. Rajacharya, Sabyasachi Bandyopadhyay, Sujoy Pal, Renu Dhingra, Rakesh Kumar, Fredrik Nikolajeff, Saroj Kumar, Neerja Rani. C1QA and COMP: plasma-based biomarkers for early diagnosis of pancreatic neuroendocrine tumors. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-48323-x
|
79 |
Dariusz Starzyński, Sylwia Rzeszotek, Agnieszka Kolasa, Marta Grabowska, Barbara Wiszniewska, Aleksandra Kudrymska, Katarzyna Karpińska, Aleksandra Tołoczko-Grabarek, Agnieszka Janiec, Aleksandra Myszka, Paweł Rynio, Anhelli Syrenicz, Elżbieta Sowińska-Przepiera. Pilot Study: FSHR Expression in Neuroendocrine Tumors of the Appendix. Journal of Clinical Medicine 2023; 12(15): 5086 doi: 10.3390/jcm12155086
|
80 |
Jiao Ma, Xiaoyong Wang, Mingsong Tang, Chunyin Zhang. Preoperative prediction of pancreatic neuroendocrine tumor grade based on 68Ga-DOTATATE PET/CT. Endocrine 2023; 83(2): 502 doi: 10.1007/s12020-023-03515-3
|
81 |
Chromogranin in the blood serum of patients with neuroendocrine tumors. Russian Clinical Laboratory Diagnostics 2023; 67(8) doi: 10.51620/0869-2084-2022-67-8-440-443
|
82 |
Hirotaka Ishida, Alfred King-yin Lam. Pancreatic neuroendocrine neoplasms: Updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification. Critical Reviews in Oncology/Hematology 2022; 172: 103648 doi: 10.1016/j.critrevonc.2022.103648
|
83 |
Costanza Chiapponi, Christiane J Bruns. Moderne molekulare und bildgebende Diagnostik bei neuroendokrinen Neoplasien des Pankreas. Die Chirurgie 2022; 93(8): 731 doi: 10.1007/s00104-022-01645-4
|
84 |
Wenzel M. Hackeng, Hussein A. Assi, Florine H.M. Westerbeke, Lodewijk A.A. Brosens, Christopher M. Heaphy. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors. Surgical Pathology Clinics 2022; 15(3): 541 doi: 10.1016/j.path.2022.05.007
|
85 |
Baltasar Pérez-Saborido, Martín Bailón-Cuadrado, Francisco Javier Tejero-Pintor, Ekta Choolani-Bhojwani, Pablo Marcos-Santos, David Pacheco-Sánchez. Recent Innovations in Surgical Procedures of Pancreatic Neoplasms. 2023; : 35 doi: 10.1007/978-3-031-21351-9_4
|
86 |
Giuseppe Fanciulli, Anna La Salvia, Sergio Di Molfetta, Giuseppe Cannavale, Giulia Puliani, Monica Verrico, Federica Campolo, Annamaria Colao, Antongiulio Faggiano. Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms. Journal of Clinical Medicine 2023; 12(24): 7557 doi: 10.3390/jcm12247557
|
87 |
Marta Opalińska, Anna Sowa-Staszczak, Helena Olearska, Magdalena Ulatowska-Bialas, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk. Clinical Approach to Neuroendocrine Neoplasm Associated With Ovarian Teratoma. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.770266
|
88 |
Laura Mariën, Odeta Islam, Siddharth Chhajlani, Willem Lybaert, Marc Peeters, Guy Van Camp, Ken Op de Beeck, Timon Vandamme. The Quest for Circulating Biomarkers in Neuroendocrine Neoplasms: a Clinical Perspective. Current Treatment Options in Oncology 2023; 24(12): 1833 doi: 10.1007/s11864-023-01147-3
|
89 |
Antonio Viúdez, Guillermo Crespo, María Luisa Gómez Dorronsoro, Imanol Arozarena, Juan Jesús Marín-Méndez, Ana Custodio, Marta Benavent, Saioa Goñi, Beatriz García-Paredes, Jorge Hernando, Maika Durantez, Vicente Alonso, María del Carmen Riesco, Carlos López, Paula Jiménez-Fonseca, Borja López San Vicente, Iranzu González-Borja, Isabel Sevilla, Irene Hernández-Garcia, Alberto Carmona-Bayonas, Jaume Capdevila, Jairo Pérez-Sanz, Rocío García-Carbonero, Leyre Pérez-Ricarte, Marta Llanos, Ruth Vera, Ana De Jesús Acosta. Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus. Pancreatology 2021; 21(1): 215 doi: 10.1016/j.pan.2020.12.009
|
90 |
Jan Krzysztof Herzyk, Karolina Majewska, Krzysztof Jakimów, Jakub Ciesielka, Joanna Pilch-Kowalczyk. Computed tomography features in prediction of histological differentiation of pancreatic neuroendocrine neoplasms – a single-centre retrospective cohort stud. Polish Journal of Radiology 2024; 89: 457 doi: 10.5114/pjr/191838
|
91 |
Venkata S. Buddhavarapu, Gagandeep Dhillon, Harpreet Singh Grewal, Brian Soles, Luke Halbur, Salim Surani, Rahul Kashyap. Transformation of pancreatic nonfunctioning neuroendocrine tumor into metastatic insulinoma: A rare case report. Clinical Case Reports 2023; 11(11) doi: 10.1002/ccr3.8152
|
92 |
Pablo Salomón Montes-Arcón, Sandra Herrera-Lomonaco, Paola María Blanco-Pertuz, Gloria Caterine Pérez-Mingan. Hipoglicemia recurrente secundaria a insulinoma pancreático. Cirujano General 2023; 45(1): 38 doi: 10.35366/110701
|
93 |
Qian Yan, Yubin Chen, Chunsheng Liu, Hexian Shi, Mingqian Han, Zelong Wu, Shanzhou Huang, Chuanzhao Zhang, Baohua Hou. Predicting histologic grades for pancreatic neuroendocrine tumors by radiologic image-based artificial intelligence: a systematic review and meta-analysis. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1332387
|
94 |
Aldona Kasprzak. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021; 9(11): 1743 doi: 10.3390/biomedicines9111743
|
95 |
Moran Drucker Iarovich, Ricarda Hinzpeter, Brian Michael Moloney, Katrina Hueniken, Patrick Veit-Haibach, Claudia Ortega, Ur Metser. Comparison of 68Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors. Current Oncology 2024; 31(1): 521 doi: 10.3390/curroncol31010036
|
96 |
Cornelius J Fernandez, Mayuri Agarwal, Biju Pottakkat, Nisha Nigil Haroon, Annu Susan George, Joseph M Pappachan. Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot. World Journal of Gastrointestinal Surgery 2021; 13(3): 231-255 doi: 10.4240/wjgs.v13.i3.231
|
97 |
Xi-Tai Huang, Jin-Zhao Xie, Chen-Song Huang, Jian-Hui Li, Wei Chen, Li-Jian Liang, Xiao-Yu Yin. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor. HPB 2022; 24(12): 2112 doi: 10.1016/j.hpb.2022.08.015
|
98 |
Andrew Canakis, Linda S Lee. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastrointestinal Endoscopy 2022; 14(5): 267-290 doi: 10.4253/wjge.v14.i5.267
|
99 |
William J. Phillips, Michelle Pradier, Rachel Goodwin, Michael Vickers, Tim Asmis. Virtual Care for Patients with Advanced Well Differentiated Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET). Current Oncology 2024; 31(2): 952 doi: 10.3390/curroncol31020071
|
100 |
Danyang Gu, Mujie Ye, Guoqin Zhu, Jianan Bai, Jinhao Chen, Lijun Yan, Ping Yu, Feiyu Lu, Chunhua Hu, Yuan Zhong, Pengfei Liu, Qibin He, Qiyun Tang. Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K/AKT/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-04870-z
|
101 |
Maja Cigrovski Berkovic, Monika Ulamec, Sonja Marinovic, Ivan Balen, Anna Mrzljak. Malignant insulinoma: Can we predict the long-term outcomes?. World Journal of Clinical Cases 2022; 10(16): 5124-5132 doi: 10.12998/wjcc.v10.i16.5124
|